$15M funding aims to advance stem cell therapies for petsJanuary 8, 2024The financing will go toward achieving the conditional U.S. Food and Drug Administration (FDA) approval of Gallant Therapeutic’s candidate for feline chronic gingivostomatitis
SPONSORED CONTENT1 dose, once a month.Defends dogs against ticks and fleas and also protects against heartworm disease, roundworms, hookworms and tapeworms. + Learn More